Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Ovarian Neoplasms

  Free Subscription

Articles published in Curr Opin Obstet Gynecol

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    February 2021
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    PubMed     Abstract available

    December 2019
    Latest clinical evidence of maintenance therapy in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 10. doi: 10.1097/GCO.0000000000000592.
    PubMed     Abstract available

  3. KUBALANZA K, Konecny GE
    Mechanisms of PARP inhibitor resistance in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 6. doi: 10.1097/GCO.0000000000000600.
    PubMed     Abstract available

    February 2019
    Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications.
    Curr Opin Obstet Gynecol. 2019;31:12-17.
    PubMed     Abstract available

    December 2018
  5. STEWART D, Cristea M
    Antibody-drug conjugates for ovarian cancer: current clinical development.
    Curr Opin Obstet Gynecol. 2018 Dec 10. doi: 10.1097/GCO.0000000000000515.
    PubMed     Abstract available

    November 2018
  6. WINTERHOFF B, Talukdar S, Chang Z, Wang J, et al
    Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.
    Curr Opin Obstet Gynecol. 2018 Nov 30. doi: 10.1097/GCO.0000000000000516.
    PubMed     Abstract available

  7. WASHINGTON C, Gunderson CC, Moore KN
    Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research.
    Curr Opin Obstet Gynecol. 2018 Nov 15. doi: 10.1097/GCO.0000000000000507.
    PubMed     Abstract available

    February 2018
    Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer.
    Curr Opin Obstet Gynecol. 2018;30:7-16.
    PubMed     Abstract available

  9. VOLPE J, Filipi JG, Cooper OR, Penson RT, et al
    Frontline therapy of ovarian cancer: trials and tribulations.
    Curr Opin Obstet Gynecol. 2018;30:1-6.
    PubMed     Abstract available

    November 2017
  10. PALEARI L, DeCensi A
    Endocrine therapy in ovarian cancer: where do we stand?
    Curr Opin Obstet Gynecol. 2017 Nov 14. doi: 10.1097/GCO.0000000000000423.
    PubMed     Abstract available

    November 2016
  11. KROEGER PT JR, Drapkin R
    Pathogenesis and heterogeneity of ovarian cancer.
    Curr Opin Obstet Gynecol. 2016.
    PubMed     Abstract available

    February 2016
  12. WALSH CS, Hodeib M
    Leveraging DNA repair deficiency in gynecologic oncology.
    Curr Opin Obstet Gynecol. 2016;28:24-31.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.